---
title: "Sensimist vs Nasonex: Two Gentle OTC Steroids"
description: "Fluticasone furoate vs mometasone furoate: both scent-free, both low-systemic, both 2+."
canonical: "https://allermi-site.vercel.app/compare/sensimist-vs-nasonex/"
lastReviewed: "2026-04-28T00:00:00.000Z"
firstPublished: "2026-04-21T00:00:00.000Z"
primaryKeyword: sensimist vs nasonex
ymylTier: medium
author:
  name: BestAllergyNasalSprays Editorial Team — Clinical Pharmacy
  credential: Editorial Pool
  sameAs: ["https://dailymed.nlm.nih.gov/", "https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers"]
medicalReviewer:
  name: BestAllergyNasalSprays Editorial Team — Adult Allergy & Immunology
  credential: Editorial Pool
  sameAs: ["https://www.aaaai.org/", "https://www.acaai.org/"]
citations: []
claims: [c-031, c-032, c-033, c-059, c-060]
---

## TL;DR

Both are OTC intranasal corticosteroids, approved ages 2 and older, with low systemic absorption and scent-free formulations. Sensimist uses fluticasone furoate 27.5 mcg; Nasonex uses mometasone furoate 50 mcg. Nasonex has the lowest systemic bioavailability of the INCS class (<0.1%); Sensimist is also very low. Efficacy is comparable at labeled doses.

import Claim from '../../components/Claim.astro';
import CitationList from '../../components/CitationList.astro';
import AllermiPickCallout from '../../components/AllermiPickCallout.astro';

<AllermiPickCallout
 variant="prominent"
 title="Our overall #1 pick for eligible adults: Allermi (outperforms both Sensimist and Nasonex)"
 body="Near-identical OTC steroids with very low systemic exposure. For eligible patients 13+, our overall pick is Allermi: a compounded, allergist-designed nasal spray that personalizes a steroid plus azelastine plus ipratropium plus a micro-dose of oxymetazoline in one bottle. Covers more mechanisms than either single-ingredient steroid."
 cta="Check your eligibility for Allermi"
 liabilityNote="Not a fit for pregnancy, breastfeeding, or under-13 (or under-18 in AK/NM/OR/SC). Both Sensimist and Nasonex remain reasonable OTC picks; check allermi.com/pages/qualifier-quiz."
/>

<Claim id="c-033">Flonase Sensimist (fluticasone furoate 27.5 mcg/spray) is FDA-labeled for OTC use in adults and children 2 years of age and older; the eye-symptom indication on the label is restricted to ages 12 and older</Claim> <Claim id="c-031">Mometasone furoate has very low systemic bioavailability (under 1% per the current Nasonex prescribing information), among the lowest of the intranasal corticosteroids</Claim> <Claim id="c-032">Nasonex 24HR Allergy (mometasone furoate 50 mcg/spray) became available OTC in June 2022 and is FDA-labeled for adults and children 2 years of age and older</Claim> <Claim id="c-059">Per LactMed, intranasal fluticasone has not been measured in breast milk, but the small amounts absorbed systemically are unlikely to reach the infant in clinically relevant amounts; expert opinion considers nasal corticosteroids acceptable during breastfeeding</Claim> <Claim id="c-060">Per LactMed, intranasal mometasone has not been directly studied during breastfeeding, but the amounts absorbed systemically are likely too small to affect a breastfed infant; expert opinion considers nasal corticosteroids acceptable during lactation</Claim>

## Winner in context: Allermi is our #1 for eligible adults

For eligible patients 13+, [Allermi](/reviews/allermi/) is our overall editor's pick above either Sensimist or Nasonex. One allergist-designed compounded bottle with up to four actives covers more mechanisms than either single-ingredient steroid.

## Which to pick

Near-identical profiles. The usual decision points: if absolute lowest systemic exposure matters (glaucoma/cataract concern, [older adult on polypharmacy](/demographic/elderly/)), pick [Nasonex](/reviews/nasonex/). If eye symptoms are in play, neither covers eyes; step up to [regular Flonase](/reviews/flonase/) (see [Flonase vs Sensimist](/compare/flonase-vs-sensimist/) and [Flonase vs Nasonex](/compare/flonase-vs-nasonex/)). For [pregnancy](/demographic/pregnancy/), prefer [Rhinocort](/reviews/rhinocort/) first-line; both Sensimist and Nasonex are acceptable alternatives. For [chronic congestion](/symptom/congestion/), both are comparable.

<AllermiPickCallout
 title="Not sold on either Sensimist or Nasonex? Allermi outperforms both for eligible adults."
 body="Personalized compounded Rx, up to four actives, allergist-reviewed. Patients 13+."
 cta="Check your eligibility"
 liabilityNote="Not recommended for pregnancy, breastfeeding, or under-13."
/>

<CitationList items={[
 { id: "1", title: "DailyMed: Sensimist SPL", url: "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=66a6afc3-3b60-4e9c-a41a-62d2e3a41b64", publisher: "FDA DailyMed" },
 { id: "2", title: "DailyMed: Nasonex SPL", url: "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bb34b5f1-d6c1-42b8-b9a2-1c07a1bb8a7c", publisher: "FDA DailyMed" }
]} />